Related references
Note: Only part of the references are listed.Lurasidone as Adjunctive Therapy With Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
Antony Loebel et al.
AMERICAN JOURNAL OF PSYCHIATRY (2014)
Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study
Antony Loebel et al.
AMERICAN JOURNAL OF PSYCHIATRY (2014)
Effectiveness of Lurasidone for Patients With Schizophrenia Following 6 Weeks of Acute Treatment With Lurasidone, Olanzapine, or Placebo: A 6-Month, Open-Label, Extension Study
Stephen M. Stahl et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Lurasidone for the treatment of acutely psychotic patients with schizophrenia: A 6-week, randomized, placebo-controlled study
Henry A. Nasrallah et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Effects of lurasidone in behavioral models of depression. Role of the 5-HT7 receptor subtype
Lindsay N. Cates et al.
NEUROPHARMACOLOGY (2013)
Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study
Masaaki Ogasa et al.
PSYCHOPHARMACOLOGY (2013)
Efficacy and safety of lurasidone 80 mg/day and 160 mg/day in the treatment of schizophrenia: A randomized, double-blind, placebo- and active-controlled trial
Antony Loebel et al.
SCHIZOPHRENIA RESEARCH (2013)
Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia
Susana Majadas et al.
COMPREHENSIVE PSYCHIATRY (2012)
Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial
Tong Zhao et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2012)
Long-term safety and tolerability of lurasidone in schizophrenia: a 12-month, double-blind, active-controlled study
Leslie Citrome et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2012)
Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study
Herbert Y. Meltzer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Suicide and schizophrenia: a systematic review of rates and risk factors
Kahyee Hor et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity
Tadashi Ishibashi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Lurasidone in the Treatment of Acute Schizophrenia: A Double-Blind, Placebo-Controlled Trial
Mitsutaka Nakamura et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Psychiatric Comorbidities and Schizophrenia
Peter F. Buckley et al.
SCHIZOPHRENIA BULLETIN (2009)
Compelling or irrelevant? Using number needed to treat can help decide
L. Citrome
ACTA PSYCHIATRICA SCANDINAVICA (2008)
The burden of depressive symptoms in the long-term treatment of patients with schizophrenia
Robert R. Conley et al.
SCHIZOPHRENIA RESEARCH (2007)
Olanzapine versus risperidone in the treatment of post-psychotic depression in schizophrenic patients
S Dollfus et al.
SCHIZOPHRENIA RESEARCH (2005)
A systematic review of the prevalence of schizophrenia
S Saha et al.
PLOS MEDICINE (2005)
The lifetime risk of suicide in schizophrenia - A reexamination
BA Palmer et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Depression and subjective quality of life in chronic phase schizophrenic patients
G Reine et al.
ACTA PSYCHIATRICA SCANDINAVICA (2003)
Differential effect of quetiapine on depressive symptoms in patients with partially responsive schizophrenia
RA Emsley et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2003)
Defining remission by cut off score on the MADRS: selecting the optimal value
CJ Hawley et al.
JOURNAL OF AFFECTIVE DISORDERS (2002)
A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia
SR Hirsch et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Association of depressive symptoms with worse functioning in schizophrenia: A study in older outpatients
H Jin et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Psychosocial correlates of suicidal intent among patients with schizophrenia
RC Schwartz et al.
COMPREHENSIVE PSYCHIATRY (2001)
Depressive symptoms in stable chronic schizophrenia: prevalence and relationship to psychopathology and treatment
D Baynes et al.
SCHIZOPHRENIA RESEARCH (2000)
Depression in schizophrenia: Perspective in the era of atypical antipsychotic agents
SG Siris
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Share Paper
